SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Incyte (INCY)
An SI Board Since January 1996
Posts SubjectMarks Bans Symbol
3202 131 0 INCY
Emcee:  scaram(o)uche Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1502nigel, Mine is spinning, too, and things aren't getting any simpler. INCY&tuck-8/18/2000
1501"Would like to do a similar license with AFFX" Amen to that. The varinigel bates-8/18/2000
1500A much more detailed discussion of the MOT deal with Roy Whitfield at:http://wLighthouse-8/18/2000
1499Aug. 18 /PRNewswire/ -- Incyte Genomics, Inc. (Nasdaq: INCY - news), the leadingnigel bates-8/18/2000
1498Rick Shhhhhh! (g) nignigel bates-8/18/2000
1497Nig: AFFX does a deal with Motorola, and adds $640 million in market cap. Iconscaram(o)uche-8/17/2000
1496PROTEOMICS AND BIOCHIPS =up 28% today INCY looks good going forward as the Protgreedsgd_2000-8/17/2000
1495Ans there I was about to post that the stock was seriously undervalued.... (FWIWnigel bates-8/17/2000
1494Thursday August 17, 9:26 am Eastern Time Press Release SOURCE: Incyte Genomics, LJM-8/17/2000
1493A bit more detail - Aug. 17 /PRNewswire/ -- Incyte Genomics, Inc. (Nasdaq: INCYnigel bates-8/17/2000
1492Thursday, August 17, 2000 MOTOROLA'S BIOCHIP SYSTEMS UNIT LICENSES INCYTE GLighthouse-8/17/2000
1491Nigel, Thanks for the clarification. Still, it is interesting that the company Torben Noerup Nielsen-8/3/2000
1490" Note the comment that Incyte views their gene patents as only a minor addnigel bates-8/2/2000
1489Note the comment that Incyte views their gene patents as only a minor addition tTorben Noerup Nielsen-8/2/2000
1488Hi Tuck I can certainly agree with this - "Looking at the near future, it nigel bates-8/2/2000
1487nigel, Welcome back. A little perspective from McCamant on patent law, with a tuck-8/2/2000
1486July 31 /PRNewswire/ -- Incyte Genomics, Inc. (Nasdaq: INCY - news), the leadingnigel bates-7/31/2000
1485INCY litigation related remarks from AFFX's conference call Question and ansim1-7/25/2000
1484I think Incyte might just be the Microsoft of the genomics industry. At least frTorben Noerup Nielsen-7/19/2000
14837/18/00 conference call notes 1. financial loss of .21 vs. consensus loss of .software salesperson-7/19/2000
1482INCY announces 2-for-1 stock split, and reports better-than-expected earnings (iRCMac-7/18/2000
1481First Announcement and Call for Papers Cambridge Healthtecsim1-7/9/2000
1480 Incyte Genomics, Inc., formerly known as Incyte PharSecret_Agent_Man-6/24/2000
1479 >>I'll take INCY substance over CRA image, thank you very much<<nigel bates-6/20/2000
1478 The press notices Celera because CRA spends time and money cultivating the presJF Quinnelly-6/19/2000
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News